ACORN CAPITAL ADVISORS, LLC
CIK 0002054410 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$366.5M
2026 Q2
Positions
20
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
90.2%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
CGON
CG ONCOLOGY INC
21.9%
URGN
UROGEN PHARMA LTD
16.8%
TRVI
TREVI THERAPEUTICS INC
10.9%
CADL
CANDEL THERAPEUTICS INC
9.8%
PBYI
PUMA BIOTECHNOLOGY INC
9.1%
JBIO
JADE BIOSCEINCES INC
6.0%
BCAX
BICARA THERAPEUTICS
5.2%
KPTI
KARYOPHARM THERAPEUTICS INC
4.0%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.